心エコー検査としても知られる心臓血管超音波システムは、体の血液動脈の循環を監視する非侵襲的な超音波法です。 心臓血管超音波システムは、心臓血管疾患の医学的診断を意味します。この装置は、医師や外科医に心臓や弁の画像を提供し、外科手術や治療に役立てられています。心血管超音波システムには、カラーとモノクロのディスプレイがあります。検査には、経胸壁心エコー検査、経食道心エコー検査、負荷心エコー検査などがあります。病院や診療所では、心血管超音波検査システムが多く導入されています。
心血管疾患は、先進国ではいまだに罹患率および死亡率の主要な原因となっており、新興国でも主要な死因となりつつあります。CVDは世界的に見ても主要な死亡原因であり、毎年、CVDが原因で亡くなる人の数は他の原因によるものよりも多くなっています。そのため、心血管障害の発生率の増加に伴い、診断用の心血管超音波システムの必要性が高まっています。
目次
Contents
1. Executive Summary
2. Global Cardiovascular Ultrasound System Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Global Cardiovascular Ultrasound System Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Global Cardiovascular Ultrasound System Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. Global Cardiovascular Ultrasound System Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Europe: (Germany, UK, and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Asia-Pacific: (China, India, Japan, South Korea, Australia, New Zealand and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Test Type: Market Share (2020-2030F)
12.2.1. Transthoracic Echocardiogram, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Transesophageal Echocardiogram, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Stress Echocardiogram, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.4. Other Echocardiograms, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Technology: Market Share (2020-2030F)
12.3.1. 2D Ultrasound, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. 3D & 4D Ultrasound, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Doppler Imaging, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By Device Display: Market Share (2020-2030F)
12.4.1. Color Display, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.2. Black & White (B/W) Display, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5. By End-User: Market Share (2020-2030F)
12.5.1. Hospital and Cardiology Centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.2. Home and Ambulatory Care Settings, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.3. Research Institutes, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.4. Medical Device and Pharmaceutical Companies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.5. Other End Users, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13. Company Profile
13.1. Chison Medical Imaging Co., Ltd
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Esaote SpA
13.3. FUJIFILM Holdings Corporation
13.4. GE Healthcare
13.5. Hitachi Medical Corporation
13.6. Mindray Medical International Ltd.
13.7. Philips Healthcare
13.8. Samsung Electronics Co., Ltd.
13.9. Siemens Healthineers
13.10. Toshiba Medical Systems Corporation
13.11. Ultrasound Technologies
13.12. Unetixs Vascular
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
